XLHealth, a Baltimore-based provider of health plan solutions for Medicare beneficiaries with special needs, announced the enrollment of its 100,000th member, and it sees room for more growth despite expected Medicare Advantage cuts
XLHealth, a Baltimore-based provider of health plan solutions for Medicare beneficiaries with special needs, announced the enrollment of its 100,000th member, and it sees room for more growth despite expected Medicare Advantage cuts.
“There is going to be increasing downward price cut pressure on all plans,” says Paul Serini, executive vice president, XLHealth. “As a starting point we’ll have that same pressure. That said, most of healthcare reform is aligned with special need plans like ours.”
He says in the next two to four years, he sees tremendous opportunities for special needs plans.
“When the dust settles from healthcare reform, any MAPD (Medicare Advantage Prescription Drug) company serving a population that’s complex enough can do a better job than traditional services,” he says. “We know we can deliver better value to our members and the Medicare system for the chronically ill.”
XLHealth focuses on a largely rural, medically underserved market and targets older members. Care Improvement Plus' chronic condition special needs plan combines medical coverage - hospital and doctors' visits - with tailored Medicare Part D prescription drug coverage and care management support for Medicare beneficiaries with diabetes and heart failure.
Care Improvement Plus launched in 2006 and now serves seniors in Arkansas, Georgia, Missouri, South Carolina, Texas and 11 Maryland counties. XLHealth estimates that approximately 7 million Medicare beneficiaries across all six states are eligible to enroll in a Care Improvement Plus plan and benefit from its model of care.
Serini says the company plans to expand in 2012. It has a target list of seven more states and 170 counties.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Opzelura May Reduce Need for Other Treatments in Atopic Dermatitis | AAD 2025
March 11th 2025Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics during the 12 months after treatment with the topical nonsteroidal, finds study at American Academy of Dermatology Association annual meeting.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Supporting Patients with Type 1 Diabetes Through Education, Technology and Transparency
March 10th 2025Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps patients with type 1 diabetes effectively use glucose monitors and insulin pumps by providing clear guidance and troubleshooting support, recognizing that even minor errors in management can have significant health consequences.
Read More
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
March 10th 2025Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma, which is a rare and aggressive type of skin cancer.
Read More